Goldman Sachs Pacific Biosciences to Raise $175M in Public Stock Offering The company is selling 17.5 million shares of its common stock at a price of $10 per share in the offering, which is expected to close Jan. 27. PerkinElmer Reaches Deal for $1.5B Credit Facility The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility. PerkinElmer Enters $500M Credit Facility The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month. Singular Genomics Ups IPO Target to $187M The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation. Sequencing Startup Singular Genomics Files for $100M IPO The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis. Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Jul 29, 2020 Sema4 Raises $121M in Series C Financing Round Jul 16, 2020 Adaptive Biotechnologies to Raise $240M in Public Stock Offering Jan 24, 2020 Adaptive Biotechnologies Prices Public Offering of Stock Jan 21, 2020 Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering Sep 25, 2019 Thermo Fisher Scientific Prices $5.7B Senior Notes Offering Aug 20, 2019 10x Genomics Files for $100M IPO Feb 27, 2019 Danaher Prices $2.76B Offering of Common, Preferred Stock Dec 8, 2015 Goldman Sachs Upgrades Myriad, Agilent, and Thermo Fisher; Downgrades PerkinElmer, Danaher Dec 18, 2014 Goldman Sachs Downgrades Qiagen, Bruker Sep 2, 2014 Goldman Sachs, Leerink Initiate Coverage of T2 Biosystems Jun 23, 2014 Goldman Sachs Reinstates Neutral Rating for Agilent Jun 25, 2013 Goldman Sachs Upgrades Waters; Downgrades Agilent, Genomic Health Apr 23, 2013 Quest Enters into Agreement to Buy Back $450M of Stock Apr 11, 2013 Goldman Sachs Upgrades Quest, LabCorp, Downgrades Sigma-Aldrich Mar 28, 2013 T2 Biosystems Raises $40M Jan 16, 2013 Goldman Sachs Survey Finds Spending on Life Science Tools Remains Challenged by Funding, Fiscal Concerns Dec 6, 2012 Goldman Sachs Resumes Coverage of Danaher with Neutral Rating Nov 19, 2012 Goldman Sachs Upgrades Agilent, Bruker; Lowers Cepheid, LabCorp Oct 11, 2012 Goldman Sachs Initiates Coverage of Genomic Health with Neutral Rating Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.